2023 annual financial data
Grace Therapeutics 2023 Operating margin
Grace Therapeutics 2023 operating margin with verified reported values.
Direct answer
Operating margin was Not calculable.
Operating income was -70,541,289 USD and net income was -57,386,566 USD.
Operating cash flow was -15,913,000 USD.
Get free Grace Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -70,541,289 USD
- Net income
- -57,386,566 USD
- Operating cash flow
- -15,913,000 USD